Waldman, Rachel
Kaplan, Harrison
Leitman, I. Michael
Article History
Received: 28 August 2022
Accepted: 1 February 2023
First Online: 23 February 2023
Declarations
:
: An IRB exemption was obtained from the Institutional Review Board at the Human Research Protection Program at the Icahn School of Medicine at Mount Sinai on February 14, 2022 (STUDY-22–00,059). This included approval for access and use of de-identified patient data from the ACS-NSQIP dataset and was granted based on the determination that this study is best classified as research not involving human subjects as defined by DHHS and FDA regulation. Informed consent was not applicable as this study involved the use of already collected, de-identified data from the ACS-NSQIP dataset.All research methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.